Results 131 to 140 of about 17,689 (274)

Drug-Excipient Compatibility Studies in Formulation Development: Current Trends and Techniques [PDF]

open access: yes, 2015
The safety, efficacy, quality and stability of a formulation are the cornerstones of any new drug development process. In order to consistently maintain these attributes in a finished dosage form, it is important to have a comprehensive understanding of ...
Dave, Vivek S   +4 more
core   +1 more source

GPCR Inhibitors Have Antiviral Properties against JC Polyomavirus Infection

open access: yesViruses
JC polyomavirus (JCPyV) infects the majority of the population and initially establishes a persistent but asymptomatic infection of the kidneys. In healthy individuals, the infection remains controlled by the host immune system, but for individuals ...
Amanda L. Sandberg   +9 more
doaj   +1 more source

Cetirizine and Loratadine: A Comparison Using the ED50 in Skin Reactions [PDF]

open access: bronze, 2000
I. Ramboer   +3 more
openalex   +1 more source

Comparison of Loratadine and Cetirizine in Perennial Allergic Rhinitis

open access: yesNovelty in Biomedicine, 2015
Background: Allergic rhinitis (AR) represents a global health problem, affecting 5-50% of the population worldwide and numerous classes of pharmacological agents are available for its treatment.
Ali Eftekharian, Kiarash Nejatpoor
doaj  

Interference of cetirizine with the late eosinophil accumulation induced by either PAF or compound 48/80 [PDF]

open access: bronze, 1992
Marco A. Martins   +7 more
openalex   +1 more source

EXPERIENCE OF CETIRIZINE SYRUP APPLICATION IN THE ATOPIC ECZEMA IN CHILDREN

open access: yesПедиатрическая фармакология, 2008
This article demonstrates the results of the scientific research, whose purpose was to study the impact of cetirizine syrup on the course of atopic eczema among 36 children (2–6 years old).
F.Ch. Shakhtakhtinskaya
doaj   +2 more sources

Effect of antihistamine up-dosing in chronic urticaria [PDF]

open access: yes, 2011
Chronic urticaria has an important impact upon patient quality of life, and no treatment has yet been developed capable of effectively controlling the disease.
Bartra, J. (J.)   +8 more
core  

Home - About - Disclaimer - Privacy